Biowearables represent a cutting-edge revolution in healthcare technology. These innovative devices are designed to monitor various physiological parameters within the human body, offering real-time insights into our health and well-being. From tracking vital signs to analyzing biochemical markers, biowearables are paving the way for personalized health monitoring and early disease detection.
Abbott Laboratories is experiencing success with its biosensor wearables in the United Kingdom, a test market preceding a planned U.S. regulatory filing by the end of this year. These devices, referred to as “biowearables,” are part of Abbott’s new Lingo line, designed to monitor glucose levels, ketones, and lactate.
These biowearables are positioned under the skin, offering precise and accurate data on an individual’s body status. Abbott, a prominent healthcare company, is already known for its products such as the top-selling continuous glucose monitor Libre and a range of diagnostic tests, including those for HIV, cancer, and various COVID-19 variants.
Abbott is introducing a new consumer biowearable called “Lingo” that goes beyond monitoring glucose levels. Lingo employs AI to provide personalized coaching plans aimed at promoting healthier habits and motivating individuals to modify their behaviors. This innovative device, already released in the UK, is set to become available globally, including in the United States, where an FDA filing is planned by year-end.
Lingo differs from Abbott’s popular Libre franchise by establishing a personalized baseline of glucose levels and tracking how various factors like diet, exercise, and sleep impact these levels, making it unique to each user.
Abbott’s Lingo biowearable features a “coaching algorithm” that assesses user data and provides guidance on areas for improvement, offering personalized recommendations for ongoing healthcare decision-making. The device utilizes a “Lingo Count” system, tracking glucose levels in real-time and assigning values to glucose spikes. Users aim to stay within their daily Lingo Count.
Abbott emphasizes that Lingo’s potential extends beyond diabetes management, envisioning it as a tool to encourage healthier behaviors and create more health-conscious individuals and societies by making health and technology converge in an intuitive and enjoyable way.
(Source: Bruce Japsen | Forbes)
